Junjeong Choi

16PUBLICATIONS
47CO-AUTHORS
Molecular targetsNanotoxicology, health and safetyPredictive and prognostic markersNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 17, 2025
Metabolomic Profiling Reveals Key Metabolic Alterations in MCF7 Tamoxifen-Resistant Cells Following EPAS1 Inhibition.

Enzhi Luo, Neeraj Manvi Agarwal, Junjeong Choi

|Jan 22, 2025
Noncanonical role of Golgi-associated macrophage TAZ in chronic inflammation and tumorigenesis.

So Yeon Park, Sungeun Ju, Jaehoon Lee

|Jan 17, 2025
Absence of Cysteine and Iron Chelation Induces Ferroptosis in Triple-Negative Breast Cancer Cells.

Manvi Agarwal Neeraj, JunJeong Choi

|Jun 30, 2024
PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways.

Seong Hun Lim, Hyesung Lee, Hyun Ji Lee

|Nov 23, 2023
Moracin E and M isolated from Morus alba Linné induced the skeletal muscle cell proliferation via PI3K-Akt-mTOR signaling pathway.

Hee Jae Kwak, Jinyoung Kim, Seo-Young Kim

|Nov 02, 2023
An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis.

Kyungsun Chae, Yeon Sook Seo, Yun Mi Yu

Pageof 3

Frequent Collaborators

2 joint publications

Ja Seung Koo

2 joint publications

Yun-Hee Lee

2 joint publications

Jones Gyamfi

2 joint publications

Jung Min Han